Integrated Diagnostics Holdings plc (IDGXF)
OTCMKTS · Delayed Price · Currency is USD
0.4854
0.00 (0.00%)
At close: Aug 26, 2025
IDGXF Revenue
Integrated Diagnostics Holdings had revenue of 1.77B EGP in the quarter ending June 30, 2025, with 33.46% growth. This brings the company's revenue in the last twelve months to 6.76B, up 42.46% year-over-year. In the year 2024, Integrated Diagnostics Holdings had annual revenue of 5.72B with 38.74% growth.
Revenue (ttm)
6.76B EGP
Revenue Growth
+42.46%
P/S Ratio
2.03
Revenue / Employee
1.07M EGP
Employees
6,309
Market Cap
276.71M USD
Revenue Chart
* This company reports financials in EGP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.72B | 1.60B | 38.74% |
Dec 31, 2023 | 4.12B | 517.46M | 14.35% |
Dec 31, 2022 | 3.61B | -1.62B | -31.00% |
Dec 31, 2021 | 5.22B | 2.57B | 96.69% |
Dec 31, 2020 | 2.66B | 429.77M | 19.30% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |